Sunday, November 9, 2008

Does big pharm control the FDA?

My guess is yes, big pharm does control the FDA. Possibly because so much of the "research" done by the FDA is funded by pharmaceutical companies.

And big pharm does not want the sale of natural health products cutting into its revenues.

Thus my email last night held a message about a new assault on our freedom. It seems the FDA, under pressure from big pharm, is hiring more agents to monitor the advertising from people selling natural health products. Those who dare to say natural products might help someone avoid illness or become well will be subject to stiff penalties, and could be put out of business entirely.

Those who advertise and sell herbal remedies, for instance, must not even mention the name of a disease or a symptom of a disease in their advertising. Talk about a way to get rid of the competition!

I suppose it makes sense. As more and more people realize the benefits of herbs and other natural supplements, and as more and more people are becoming ill from pharmaceuticals, big pharm knows that many will shift from trusting them to mis-trusting them - and will switch to natural remedies with no evil side-effects.

So... they promote the idea that natural products should be regulated because they might be "dangerous" to the public. Never mind that nearly all of the products they sell carry the risk of serious disability or death.

Thank goodness we are all free to do our own research and find out just what good things herbs, vitamins, and supplements such as mangosteen can do for us. I keep a copy of Dr. Tanton's "A Drug Free Approach to Health Care" by my desk, because I know he's done years of research into natural health. It's a great place to start - and if I want to know more, there's always Google.

I firmly believe that every person should research the side effects before taking any medication - and should explore natural alternatives before taking the risk that pharmaceuticals present. Even if it does mean lost revenue for big pharm.

No comments: